These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 27150247)

  • 1. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
    Chen Y; Wu Y; Sun B; Liu S; Liu H
    Small; 2017 Mar; 13(10):. PubMed ID: 28075057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
    Zhou LQ; Li P; Cui XW; Dietrich CF
    Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 6. Supramolecular cancer nanotheranostics.
    Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
    Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphene-like Metal-Free 2D Nanosheets for Cancer Imaging and Theranostics.
    Luo Y; Li Z; Zhu C; Cai X; Qu L; Du D; Lin Y
    Trends Biotechnol; 2018 Nov; 36(11):1145-1156. PubMed ID: 29954613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fe
    Li Y; Zhang H
    Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in two-dimensional molybdenum disulfide-based multimodal cancer theranostics.
    Yu X; Xu C; Sun J; Xu H; Huang H; Gan Z; George A; Ouyang S; Liu F
    J Nanobiotechnology; 2024 Aug; 22(1):515. PubMed ID: 39198894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics - a sure cure for cancer after 100 years?
    Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
    Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
    Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
    Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
    Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
    Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 17. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
    ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Molecular Machines in Nanotheranostics.
    Yu G; Yung BC; Zhou Z; Mao Z; Chen X
    ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.